ENOV
Enovis Corporation · Healthcare · Medical - Devices
Momentum inputs (comparable managers): holder breadth 0.0% · share flow +1.1% · net new positions 0.0% · formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 148.61K | $2.70M | n/a | n/a |
| Q2 2026 | 91 | +1 | 44.48M | $916.26M | +11 | −11 |
| Q1 2026 | 94 | 0 | 43.44M | $983.72M | +7 | −7 |
| Q4 2025 | 94 | 0 | 46.98M | $1.22B | +1 | −1 |
| Q3 2025 | 15 | 0 | 23.49M | $712.80M | +1 | −1 |
| Q2 2025 | 12 | -1 | 21.15M | $663.36M | +1 | −2 |
| Q1 2025 | 10 | -3 | 4.37M | $166.84M | +1 | −4 |
| Q4 2024 | 13 | +2 | 4.81M | $211.07M | +3 | −1 |
| Q3 2024 | 10 | 0 | 3.56M | $153.33M | +1 | −1 |
| Q2 2024 | 10 | n/a | 3.60M | $162.77M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passive) | 8.88M | -0.6% | $269.33M | 0.0% | ▼ Trim | 2 | SEC ↗ ×17 |
| 2 | The Vanguard Group ✦ (passive) | 6.52M | +2.0% | $197.95M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (passive) | 2.35M | -5.6% | $71.26M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 4 | Geode Capital Management ✦ (passive) | 1.35M | +0.9% | $41.12M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 5 | Fidelity (FMR) ✦ | 1.26M | +19756.0% | $38.37M | 0.0% | ▲ Add | 2 | SEC ↗ ×4 |
| 6 | Morgan Stanley ✦ | 976.32K | n/a | $29.62M | 0.0% | n/c | 1 | SEC ↗ ×14 |
| 7 | Goldman Sachs Group ✦ | 621.17K | n/a | $18.85M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 8 | Citadel Advisors ✦ | 517.42K | -44.6% | $15.70M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 9 | JPMorgan Chase ✦ | 495.17K | n/a | $15.02M | 0.0% | n/c | 1 | SEC ↗ ×10 |
| 10 | Millennium Management ✦ | 336.34K | +90.8% | $10.20M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 11 | Point72 Asset Management ✦ | 61.16K | -75.1% | $1.86M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 12 | T. Rowe Price ✦ | 54.91K | +14.5% | $1.67M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 34.64K | -93.0% | $1.05M | 0.0% | ▼ Trim | 6 | SEC ↗ ×5 |
| 14 | GAMCO Investors ✦ | 19.72K | +43.3% | $598,335 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 15 | D. E. Shaw & Co. ✦ | 6.97K | New | $211,409 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| D. E. Shaw & Co. | $211,409 | 0.0% |
Exited
| Renaissance Technologies | $2.38M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 4 holders, 12.22M shares, $11.78M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
Officer · Chief Administrative… · 2.66K sh @ 18.80 · $50,008
Officer, Director · Chief Executive… · 13.04K sh @ 19.15 · $249,620
Officer · Chief Administrative… · 5.14K sh @ 19.46 · $100,024
Officer · Chief Administrative… · 2.46K sh @ 20.32 · $49,947
Open-market sales (S)
No open-market insider sales in our coverage window.
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology